Online Only Articles

Disease progression in myeloproliferative neoplasms: comparing patients in accelerated phase with those in chronic phase with increased blasts (<10%) or with other types of disease progression

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA
Department of Medicine, Weill Cornell Medicine, New York, NY, USA
Hematology Division, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy
Department of Pathology, Massachusetts General Hospital, Boston, MA, USA
IRCCS San Raffaele Scientific Institute, Milan, Italy
IRCCS San Raffaele Scientific Institute, Milan, Italy
Department of Medicine, Weill Cornell Medicine, New York, NY, USA
IRCCS San Raffaele Scientific Institute, Milan, Italy
Department of Pathology, Massachusetts General Hospital, Boston, MA, USA
Division of Pathology, Department of Pathophysiology and Transplantation, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy
Hematology Division, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy
Department of Pathology, Texas Tech University, El Paso, TX, USA
Vol. 105 No. 5 (2020): May, 2020 https://doi.org/10.3324/haematol.2019.230193